Professor of Radiotherapeutics and Radioimaging
- Group Leader, Oxford Institute for Radiation Oncology
- Honorary Consultant in Clinical Oncology, Oxford University Hospitals NHS Trust
My research is interested in personalising radiotherapy using functional imaging: we apply functional and molecular imaging techniques to developing radiotherapy personalised to each patients’ individual tumour biology.
Katherine undertook specialist training in Clinical Oncology at the Hammersmith Hospital and doctoral research at Edinburgh University. In 1995 she was appointed as Staff Radiation Oncologist at the Princess Margaret Hospital and Scientist at the Ontario Cancer Institute, Toronto. She returned to the UK in 2006 to join the Oxford Institute and establish the Radiotherapeutics and Radioimaging Group.
Marculescu C. et al, (2019), Chem Commun (Camb)
Manganese-free chow, a refined non-invasive solution to reduce gastrointestinal signal for T1-weighted MRI of the mouse abdomen.
KERSEMANS V. et al, (2019), Laboratory Animals
Lee BQ. et al, (2019), Phys Med Biol
Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)
McGowan DR. et al, (2019), Eur J Cancer, 113, 87 - 95